Financhill
Buy
81

GMED Quote, Financials, Valuation and Earnings

Last price:
$88.50
Seasonality move :
2.85%
Day range:
$88.52 - $89.85
52-week range:
$51.79 - $94.93
Dividend yield:
0%
P/E ratio:
28.69x
P/S ratio:
4.42x
P/B ratio:
2.70x
Volume:
1.3M
Avg. volume:
1.7M
1-year change:
6.82%
Market cap:
$11.9B
Revenue:
$2.5B
EPS (TTM):
$3.09

Earnings Data

Next earnings date for GMED
Feb 19
2026
Most recent earnings per share
$0.88
Beat by $0.10
(Nov 6/2025)
Consensus Estimate
$0.78
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GMED Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/19/2026 Q4 $778.3M -- -- $1.09 --
11/06/2025 Q3 $736.6M $769M $0.88 $0.78 $0.10
08/07/2025 Q2 $742.7M $745.3M $1.49 $0.75 $0.74
05/08/2025 Q1 $625.9M $598.1M $0.54 $0.75 -$0.21
02/20/2025 Q4 $646.2M $657.3M $0.19 $0.75 -$0.56
11/05/2024 Q3 $604.8M $625.7M $0.38 $0.65 -$0.27
08/06/2024 Q2 $615.4M $629.7M $0.23 $0.68 -$0.45
05/07/2024 Q1 $589.6M $606.7M -$0.05 $0.57 -$0.62
02/20/2024 Q4 $608.2M $616.5M $0.11 $0.61 -$0.50
11/07/2023 Q3 -- $383.6M $0.01 -- --
08/03/2023 Q2 -- $291.6M $0.57 -- --
05/04/2023 Q1 -- $276.7M $0.48 -- --
02/21/2023 Q4 -- $274.5M $0.49 -- --
11/08/2022 Q3 -- $254.1M $0.47 -- --
08/04/2022 Q2 -- $263.6M $0.53 -- --
05/10/2022 Q1 -- $230.5M $0.37 -- --
02/17/2022 Q4 -- $250M $0.15 -- --
11/04/2021 Q3 -- $229.7M $0.45 -- --
08/04/2021 Q2 -- $251M $0.40 -- --
05/04/2021 Q1 -- $227.3M $0.44 -- --
02/17/2021 Q4 -- $233.4M $0.52 -- --
10/28/2020 Q3 -- $216.1M $0.44 -- --
08/05/2020 Q2 -- $148.9M -$0.21 -- --
05/07/2020 Q1 -- $190.6M $0.25 -- --
02/20/2020 Q4 -- $211.7M $0.44 -- --
11/06/2019 Q3 -- $196.2M $0.38 -- --
08/01/2019 Q2 -- $194.5M $0.38 -- --
05/02/2019 Q1 -- $182.9M $0.33 -- --
02/21/2019 Q4 -- $195.9M $0.36 -- --
11/08/2018 Q3 -- $169.2M $0.35 -- --
08/01/2018 Q2 -- $173.4M $0.44 -- --
05/02/2018 Q1 -- $174.4M $0.39 -- --
02/21/2018 Q4 -- $176M $0.25 -- --
11/08/2017 Q3 -- $151.7M $0.26 -- --
08/02/2017 Q2 -- $152.4M $0.29 -- --
05/17/2017 Q1 -- $155.8M $0.30 -- --
02/27/2017 Q4 -- $151.6M $0.25 -- --
11/08/2016 Q3 -- $135.7M $0.27 -- --
07/26/2016 Q2 -- $137.5M $0.27 -- --
05/03/2016 Q1 -- $139.3M $0.29 -- --
02/24/2016 Q4 -- $142.6M $0.39 -- --

Globus Medical, Inc. Earnings Questions

  • How Much did Globus Medical, Inc. Generate in Revenue Last Quarter?

    Globus Medical, Inc. reported $769M worth of top line sales in its most recent quarter.

  • Did Globus Medical, Inc. Beat Earnings Last Quarter?

    Globus Medical, Inc. announced earnings per share of $0.88 which represents a beat of analyst forecast a $0.78 per share.

  • Is Globus Medical, Inc. Profitable?

    Globus Medical, Inc. reported $486.7M that represents $3.59 per share over the last quarter.

  • What is the Analyst Consensus for Globus Medical, Inc. EPS Next Year?

    Globus Medical, Inc.'s earnings are forecast to grow from $0.75 per share to $2.99 per share next year representing an increase of 408.01%.

  • When is Globus Medical, Inc.'s Earnings Date?

    Globus Medical, Inc.'s next earnings date is February 19, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock